US Stock MarketDetailed Quotes

PDSB PDS Biotechnology

Watchlist
  • 3.230
  • +0.030+0.94%
Close Nov 4 16:00 ET
118.93MMarket Cap-2626P/E (TTM)

About PDS Biotechnology Company

PDS Biotechnology Corp. engages in the development of clinical-stage immunotherapies to treat various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its product, PDS0101, is an off the shelf immunotherapeutic that is administered by subcutaneous injection. The company was founded by Frank K. Bedu-Addo in 2005 and is headquartered in Princeton, NJ.

Company Profile

SymbolPDSB
Company NamePDS Biotechnology
Listing DateOct 1, 2015
Issue Price11.00
Founded2005
CEODr. Frank Bedu-Addo, PhD
MarketNASDAQ
Employees25
Fiscal Year Ends12-31
Address303A College Road East
CityPrinceton
ProvinceNew Jersey
CountryUnited States of America
Zip Code08540
Phone1-800-208-3343

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Frank Bedu-Addo, PhD
  • Director, President and Chief Executive Officer
  • 5.01M
  • Dr. Kirk V. Shepard, M.D.
  • Chief Medical Officer
  • --
  • Stephan F. Toutain, M.B.A.,M.S.
  • Chief Operations Officer
  • --
  • Lars Boesgaard
  • Chief Financial Officer and Principal Accounting Officer
  • --
  • Gregory L. Conn
  • Chief Scientific Officer
  • 1.68M
  • Spencer D. Brown
  • Senior Vice President, General Counsel and Chief Compliance Officer
  • --
  • Stephen C. Glover
  • Chairman of the Board
  • 135.99K
  • Dr. Ilian Petkov Iliev
  • Director
  • 82.99K
  • Kamil Ali-Jackson, Esq.
  • Independent Director
  • 106.49K
  • Gregory G. Freitag, C.P.A.,J.D.
  • Independent Director
  • 105.49K
  • Dr. Otis W. Brawley,M.D.
  • Independent Director
  • 82.99K
  • Sir Richard Brook Sykes
  • Independent Director
  • 94.49K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data